Skip to content
Search
Facebook
 
ADCSADCS
ADCS
Alzheimer's Disease Cooperative Study
  • About Us
    • About ADCS
    • Meet the Directors
    • ADCS Cores
    • ADCS Clinical Trials Network
    • Steering Committee Voting Members
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Clinical Trials
    • Study Newsletters
    • Research News
    • Alzheimer’s Study Quilt Project
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biospecimen Bank
    • ADCS Instruments
    • Proposal Submission
  • CTMS
    • Clinical Conductor Enterprise
    • Clinical Conductor Site Portals
  • Donate
  • Steering Committee Members
  • Staff Resources
  • About Us
    • About ADCS
    • Meet the Directors
    • ADCS Cores
    • ADCS Clinical Trials Network
    • Steering Committee Voting Members
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Clinical Trials
    • Study Newsletters
    • Research News
    • Alzheimer’s Study Quilt Project
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biospecimen Bank
    • ADCS Instruments
    • Proposal Submission
  • CTMS
    • Clinical Conductor Enterprise
    • Clinical Conductor Site Portals
  • Donate
  • Steering Committee Members
  • Staff Resources

Blog

You are here:
    Home

Home Based Assessments Trial Primary Paper in the Journal of Alzheimer’s & Dementia

Research NewsBy Genny MathewsMarch 22, 2019

Led by Mt Sinai Alzheimer’s researcher and thought leader Mary Sano, PhD, and coordinated by the ADCS, the HBA study compared feasibility and efficiency, and ability to capture change over time using in-home instruments, and ability to predict cognitive conversion using pre-defined triggers in a randomized clinical trial.

“Young Latino’s Working in Alzheimer’s” Airs Tonight on UCSD TV and is Streaming on the Brain Channel

Research NewsBy Genny MathewsMarch 7, 2019

Watch a Brain Channel round table about educating, training, mentoring and funding young Latino Alzheimer’s scientists.

40 Sites Across The Country To Test New Alzheimer’s Drug

Research NewsBy ADCS AdminMarch 6, 2019

Newly discovered Alzheimer’s genes lead to hope for future treatments

Research NewsBy ADCS AdminMarch 4, 2019

ADCS Director Howard Feldman, MD talks about the T2 Protect trial and a bright future for Alzheimer’s research

Research NewsBy Genny MathewsFebruary 11, 2019

2018 Alzheimer’s Association Facts & Figures Released

Research NewsBy ADCS AdminMarch 22, 2018

Raskin, Peskind NEJM Article on Prazosin for PTSD in Veterans

Research NewsBy ADCS AdminFebruary 16, 2018

What’s next in the Raskind/Peskind Prazosin research? They are directing the ADCS’ Peace AD trial which will test Prazosin, as a treatment for disruptive agitation, in people with moderate to severe Alzheimer’s disease. The trial is launching this spring in over 20 memory and long term care communities in the US.

FDA’s Early AD Draft Guidance for Industry on Drug Development for Treatments in Early Alzheimer’s Disease

Research NewsBy ADCS AdminFebruary 16, 2018

The AlzForum’s 2017 Year in AD Research

Research NewsBy ADCS AdminJanuary 8, 2018

The AlzForum’s editorial team provides a comprehensive recap of the last year in Alzheimer’s research and related public policy developments.

American Academy of Neurology Updates Practice Guideline for Mild Cognitive Impairment (MCI)

Research NewsBy ADCS AdminJanuary 5, 2018

The updated guidelines reflect increased MCI research, the significance of MCI in clinical practice, and therapeutics in trials.

12345…
67
8
ADCS Research News
  • Home Based Assessments Trial Primary Paper in the Journal of Alzheimer’s & Dementia
  • “Young Latino’s Working in Alzheimer’s” Airs Tonight on UCSD TV and is Streaming on the Brain Channel
  • 40 Sites Across The Country To Test New Alzheimer’s Drug
  • Newly discovered Alzheimer’s genes lead to hope for future treatments
  • ADCS Director Howard Feldman, MD talks about the T2 Protect trial and a bright future for Alzheimer’s research
About ADCS
The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California San Diego.
Contact Us
  • E-mail:
    alzinfo@ucsd.edu
  • Phone:
    858-246-1333

Find us on:

FacebookRssMail
Location
Shipping Address:
9452 Medical Center Drive
4th Floor
La Jolla, CA 92037

Mailing Address:
9500 Gilman Dr
MC0949
La Jolla, CA 92093-0949
Copyright 2017 Regents of the University of California.